Mahboobeh Moradi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mahboobeh Moradi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Elham Rasoulian Barzoki1 shared publication
- Khadije Jahangasht Ghoozlu
Department of Nursing, Nursing Care Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
1 shared publication - Mahsa Ovliaei Bidgoli
Department of Nursing, KaMS.C., Islamic Azad University, Kashan, Iran
1 shared publication - Masome Rahimi
Critical Care Nursing, Motahari Hospital, Jahrom University of Medical Sciences, Jahrom, Iran
1 shared publication - Samaneh Marofi1 shared publication
- Samira Ahmadi
Social Determinants of Health Research Center, Health and Metabolic Diseases Research Institute, Zanjan University of Medical Sciences, Zanjan, Iran
1 shared publication
Latest Publications
- Open Access
- 29 September 2025
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 24 (1) , 1-14
Effects of topical ozonated olive oil on lipid profile, quality of life, wound healing and glycemic control in patients with diabetic foot ulcers: a randomized controlled trial
Diabetic foot ulcers (DFUs) are a severe complication of diabetes, leading to infections, amputations, and reduced quality of life. Ozonated olive oil, combining ozone’s antimicrobial properties with olive oil’s biocompatibility, shows promise in chronic wound management. Limited evidence exists on its comprehensive effects in DFUs. This study evaluates its impact on wound healing, quality of life, glycemic control, lipid profiles, and inflammation. A randomized controlled trial was conducted at a tertiary care center in Hormozgan Province (January–December 2024) with 123 adults (aged 18–75) with type-2 diabetes and Wagner grade 1–2 DFUs. Participants were randomized (1:1) to receive daily topical ozonated olive oil (50 g/m³, 5 mL) or standard care for 4 weeks. Outcomes included wound severity (Bates-Jensen Wound Assessment Tool [BWAT]), quality of life (Diabetes Quality of Life Questionnaire [DQOL]), glycemic control (Glycated Hemoglobin [HbA1c], Fasting Blood Glucose [FBG], Postprandial Glucose [PPG]), lipid profiles (Low-Density Lipoprotein [LDL], High-Density Lipoprotein [HDL], Triglycerides [TG], Total Cholesterol), and inflammatory markers (High-Sensitivity C-Reactive Protein [hs-CRP], Interleukin-6 [IL-6], Tumor Necrosis Factor-alpha [TNF-α]). Assessments occurred at baseline, post-intervention, and 4 weeks post-intervention. Linear Mixed Models (LMM) and Analysis of Covariance (ANCOVA) analyzed outcomes, adjusting for baseline values. The intervention group (n = 62) showed significant improvements compared to controls (n = 61). Bates-Jensen scores decreased (22.3 ± 4.5 vs. 26.1 ± 4.9, p < 0.001, Cohen’s d = 0.67) at 4 weeks post-intervention, indicating better wound healing. Quality of life scores improved (50.1 ± 9.5 vs. 57.8 ± 10.0, p < 0.001, Cohen’s d = 0.72). HbA1c reduced (7.1 ± 1.0% vs. 7.7 ± 1.1%, p = 0.005, Cohen’s d = 0.51), as did fasting (145.3 ± 22.5 vs. 158.7 ± 23.9 mg/dL, p = 0.015) and postprandial glucose (190.1 ± 31.5 vs. 210.2 ± 33.8 mg/dL, p = 0.009). Also, hs-CRP levels dropped (2.9 ± 1.0 vs. 3.6 ± 1.1 mg/L, p = 0.006, Cohen’s d = 0.50), but IL-6/TNF-α and lipid profiles showed no significant changes (p > 0.05). Topical ozonated olive oil significantly enhances wound healing, quality of life, glycemic control, and reduces inflammation in DFU patients. Its affordability and efficacy make it a promising adjunctive therapy. Further studies should explore long-term effects and mechanisms. It offers a scalable solution for DFU management.
- 29 September 2025
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 24 (1) , 1-14
Open AccessEffects of topical ozonated olive oil on lipid profile, quality of life, wound healing and glycemic control in patients with diabetic foot ulcers: a randomized controlled trial
Diabetic foot ulcers (DFUs) are a severe complication of diabetes, leading to infections, amputations, and reduced quality of life. Ozonated olive oil, combining ozone’s antimicrobial properties with olive oil’s biocompatibility, shows promise in chronic wound management. Limited evidence exists on its comprehensive effects in DFUs. This study evaluates its impact on wound healing, quality of life, glycemic control, lipid profiles, and inflammation. A randomized controlled trial was conducted at a tertiary care center in Hormozgan Province (January–December 2024) with 123 adults (aged 18–75) with type-2 diabetes and Wagner grade 1–2 DFUs. Participants were randomized (1:1) to receive daily topical ozonated olive oil (50 g/m³, 5 mL) or standard care for 4 weeks. Outcomes included wound severity (Bates-Jensen Wound Assessment Tool [BWAT]), quality of life (Diabetes Quality of Life Questionnaire [DQOL]), glycemic control (Glycated Hemoglobin [HbA1c], Fasting Blood Glucose [FBG], Postprandial Glucose [PPG]), lipid profiles (Low-Density Lipoprotein [LDL], High-Density Lipoprotein [HDL], Triglycerides [TG], Total Cholesterol), and inflammatory markers (High-Sensitivity C-Reactive Protein [hs-CRP], Interleukin-6 [IL-6], Tumor Necrosis Factor-alpha [TNF-α]). Assessments occurred at baseline, post-intervention, and 4 weeks post-intervention. Linear Mixed Models (LMM) and Analysis of Covariance (ANCOVA) analyzed outcomes, adjusting for baseline values. The intervention group (n = 62) showed significant improvements compared to controls (n = 61). Bates-Jensen scores decreased (22.3 ± 4.5 vs. 26.1 ± 4.9, p < 0.001, Cohen’s d = 0.67) at 4 weeks post-intervention, indicating better wound healing. Quality of life scores improved (50.1 ± 9.5 vs. 57.8 ± 10.0, p < 0.001, Cohen’s d = 0.72). HbA1c reduced (7.1 ± 1.0% vs. 7.7 ± 1.1%, p = 0.005, Cohen’s d = 0.51), as did fasting (145.3 ± 22.5 vs. 158.7 ± 23.9 mg/dL, p = 0.015) and postprandial glucose (190.1 ± 31.5 vs. 210.2 ± 33.8 mg/dL, p = 0.009). Also, hs-CRP levels dropped (2.9 ± 1.0 vs. 3.6 ± 1.1 mg/L, p = 0.006, Cohen’s d = 0.50), but IL-6/TNF-α and lipid profiles showed no significant changes (p > 0.05). Topical ozonated olive oil significantly enhances wound healing, quality of life, glycemic control, and reduces inflammation in DFU patients. Its affordability and efficacy make it a promising adjunctive therapy. Further studies should explore long-term effects and mechanisms. It offers a scalable solution for DFU management.
- Open Access
- 2 July 2025
- Published by Brieflands in Journal of Nursing and Midwifery Sciences
- Vol. 12 (3)
The Relationship Between Nomophobia and Clinical Performance Among Iranian Nursing Students: A Cross-sectional Study
Background: Nomophobia, the fear of being without a mobile phone, is increasingly prevalent among nursing students and may impact their clinical performance. Understanding this relationship is essential for developing strategies to enhance focus and professional competence in clinical settings. This study aimed to address this research gap by investigating the relationship between nomophobia and clinical performance among nursing students. Objectives: This study aimed to address this research gap by investigating the relationship between nomophobia and clinical performance among nursing students. Methods: A cross-sectional study was conducted from September 2024 to January 2025 to examine the relationship between nomophobia and clinical performance among nursing students at Islamic Azad University of Kashan and Kashan University of Medical Sciences. Using a convenience sampling method, 200 undergraduate nursing students aged 19 - 27 years were recruited. Data were collected through self-administered pencil-and-paper questionnaires, including the Nomophobia Questionnaire (NMP-Q) to assess nomophobia levels and the Clinical Performance Questionnaire to evaluate self-efficacy in clinical performance. Statistical analyses were conducted using SPSS version 26, employing a general linear model (GLM) to assess the impact of nomophobia on clinical performance while controlling for demographic variables. Results: Among the participants, 62.5% were female, and 70.5% were aged 19 - 21 years. Moderate nomophobia was the most prevalent (56%), followed by mild (29%) and severe nomophobia (4%). The GLM analysis revealed that nursing students with mild nomophobia had significantly higher clinical performance scores (B = 34.24, P = 0.002) compared to those with severe nomophobia. Additionally, students who checked their smartphones 10 - 29 times per day had significantly higher clinical performance scores (B = 22.19, P = 0.01) than those who checked their phones more than 100 times daily. Gender (B = -10.09, P = 0.01) and smartphone ownership duration (B = -14.20, P = 0.02) also demonstrated significant associations with clinical performance. Conclusions: This study found that higher levels of nomophobia were associated with lower clinical performance in nursing students. Moderate smartphone use appeared to correlate with better clinical outcomes, while excessive checking was linked to reduced performance. Future interventions should focus on managing smartphone use to enhance nursing students' clinical efficiency.
- 2 July 2025
- Published by Brieflands in Journal of Nursing and Midwifery Sciences
- Vol. 12 (3)
Open AccessThe Relationship Between Nomophobia and Clinical Performance Among Iranian Nursing Students: A Cross-sectional Study
Background: Nomophobia, the fear of being without a mobile phone, is increasingly prevalent among nursing students and may impact their clinical performance. Understanding this relationship is essential for developing strategies to enhance focus and professional competence in clinical settings. This study aimed to address this research gap by investigating the relationship between nomophobia and clinical performance among nursing students. Objectives: This study aimed to address this research gap by investigating the relationship between nomophobia and clinical performance among nursing students. Methods: A cross-sectional study was conducted from September 2024 to January 2025 to examine the relationship between nomophobia and clinical performance among nursing students at Islamic Azad University of Kashan and Kashan University of Medical Sciences. Using a convenience sampling method, 200 undergraduate nursing students aged 19 - 27 years were recruited. Data were collected through self-administered pencil-and-paper questionnaires, including the Nomophobia Questionnaire (NMP-Q) to assess nomophobia levels and the Clinical Performance Questionnaire to evaluate self-efficacy in clinical performance. Statistical analyses were conducted using SPSS version 26, employing a general linear model (GLM) to assess the impact of nomophobia on clinical performance while controlling for demographic variables. Results: Among the participants, 62.5% were female, and 70.5% were aged 19 - 21 years. Moderate nomophobia was the most prevalent (56%), followed by mild (29%) and severe nomophobia (4%). The GLM analysis revealed that nursing students with mild nomophobia had significantly higher clinical performance scores (B = 34.24, P = 0.002) compared to those with severe nomophobia. Additionally, students who checked their smartphones 10 - 29 times per day had significantly higher clinical performance scores (B = 22.19, P = 0.01) than those who checked their phones more than 100 times daily. Gender (B = -10.09, P = 0.01) and smartphone ownership duration (B = -14.20, P = 0.02) also demonstrated significant associations with clinical performance. Conclusions: This study found that higher levels of nomophobia were associated with lower clinical performance in nursing students. Moderate smartphone use appeared to correlate with better clinical outcomes, while excessive checking was linked to reduced performance. Future interventions should focus on managing smartphone use to enhance nursing students' clinical efficiency.